Opthea
Clinical-stage biopharmaceutical company developing novel therapies for retinal diseases, with lead candidate sozinibercept targeting wet age-related macular degeneration and diabetic macular edema.
Website
https://www.opthea.comLocation
Melbourne, Australia
Founded
2007
Investors
1
Categories
biotech, ophthalmology, retinal-diseases, wet-amd
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |